Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Biological Therapy in Treating Patients With Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx
- Status
- COMPLETED
- Phase
- PHASE1
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
- Status
- COMPLETED
- Phase
- PHASE3
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
- Status
- TERMINATED
- Phase
- PHASE3
Radiation Therapy Following Surgery in Treating Patients With Recurrent or Second Primary Cancer of the Head and Neck Following Previous Radiation Therapy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx
- Status
- UNKNOWN
- Phase
- PHASE2
Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fenretinide in Treating Patients With Leukoplakia of the Mouth
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
- Status
- UNKNOWN
- Phase
- PHASE2